(Q77425207)
Statements
A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu (English)
V Pullarkat
Y Deo
J Link
L Spears
V Marty
R Curnow
S Groshen
C Gee